Buprigesic Patch 5
By Buprigesic
Rx
2es Transdermal Patch in a Boxes

Composition
Buprenorphine(5mg)

Manufacturer - Neon Laboratories Ltd
140, Damji Samji Industrial Complex, Mahakali Caves Rd., Andheri(East), Mumbai-93.

Expires on or after
August, 2025

liver
When using Buprigesic Patch 5, it is important to be cautious if you have severe liver disease. In such cases, it may be necessary to adjust the dosage of the patch. It is advisable to consult your doctor before using this patch if you have a history of liver disease. Additionally, patients with severe hepatic impairment may want to consider using an alternative pain reliever that allows for more flexible dosing. Always keep your healthcare provider informed about any pre-existing liver conditions to ensure safe use of Buprigesic Patch 5.

kidney
Buprigesic Patch 5 requires caution in individuals with severe kidney disease, possibly needing dosage adjustment. Inform your doctor if you have kidney issues before using Buprigesic Patch 5.

alcohol
It is important not to consume alcohol or other drugs while using Buprigesic Patch 5 to avoid serious risks. Avoid alcohol, alcohol-based medications, and street drugs during treatment.

driving
Caution is advised when driving after using Buprigesic Patch 5, as it may lead to dizziness, blurred vision, or drowsiness. Avoid driving if you feel drowsy, dizzy, or have vision issues post-application of the patch.

pregnancy
Buprigesic Patch 5 is considered unsafe during pregnancy due to potential harm to the developing baby, as indicated by animal studies. Consult your doctor if you are pregnant or planning pregnancy, as it may cause withdrawal symptoms in newborns. If your baby shows certain symptoms, seek medical help promptly.

breastfeeding
Buprigesic Patch 5 may not be safe to use while breastfeeding as it could pass into breastmilk and potentially harm the baby. If nursing, it is advisable to avoid using this patch, as buprenorphine in it may lead to respiratory problems in infants. Consult your doctor for alternative pain relief options.
Habit Forming | Yes |
Chemical Class | Phenanthrenes Derivatives |
Therapeutic Class | - |
Action Class | Opioids- Partial agonist |
₹1516
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024